Regulation of FN1 degradation by the p62/SQSTM1-dependent autophagy–lysosome pathway in HNSCC

Abstract

Epithelial–mesenchymal transition (EMT) is involved in both physiological and pathological processes. EMT plays an essential role in the invasion, migration and metastasis of tumours. Autophagy has been shown to regulate EMT in a variety of cancers but not in head and neck squamous cell carcinoma (HNSCC). Herein, we investigated whether autophagy also regulates EMT in HNSCC. Analyses of clinical data from three public databases revealed that higher expression of fibronectin-1 (FN1) correlated with poorer prognosis and higher tumour pathological grade in HNSCC. Data from SCC-25 cells demonstrated that rapamycin and Earle’s balanced salt solution (EBSS) promoted autophagy, leading to increased FN1 degradation, while 3-methyladenine (3-MA), bafilomycin A1 (Baf A1) and chloroquine (CQ) inhibited autophagy, leading to decreased FN1 degradation. On the other hand, autophagic flux was blocked in BECN1 mutant HNSCC Cal-27 cells, and rapamycin did not promote autophagy in Cal-27 cells; also in addition, FN1 degradation was inhibited. Further, we identified FN1 degradation through the lysosome-dependent degradation pathway using the proteasome inhibitor MG132. Data from immunoprecipitation assays also showed that p62/SQSTM1 participated as an autophagy adapter in the autophagy–lysosome pathway of FN1 degradation. Finally, data from immunoprecipitation assays demonstrated that the interaction between p62 and FN1 was abolished in p62 mutant MCF-7 and A2780 cell lines. These results indicate that autophagy significantly promotes the degradation of FN1. Collectively, our findings clearly suggest that FN1, as a marker of EMT, has adverse effects on HNSCC and elucidate the autophagy–lysosome degradation mechanism of FN1.

References

[1] Nieto MA, Huang RY, Jackson RA, Thiery JP. Emt: 2016. Cell, 2016, 166: 21-45.

[2] Dongre A, Weinberg RA. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat. Rev. Mol. Cell Biol., 2019, 20: 69-84.

[3] Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J. Clin. Invest., 2009, 119: 1420-1428.

[4] Brabletz T, Kalluri R, Nieto MA, Weinberg RA. EMT in cancer. Nat. Rev. Cancer, 2018, 18: 128-134.

[5] Zeisberg M, Neilson EG. Biomarkers for epithelial-mesenchymal transitions. J. Clin. Invest., 2009, 119: 1429-1437.

[6] Kosmehl H, . Distribution of laminin and fibronectin isoforms in oral mucosa and oral squamous cell carcinoma. Br. J. Cancer, 1999, 81: 1071-1079.

[7] Rybak JN, Roesli C, Kaspar M, Villa A, Neri D. The extra-domain A of fibronectin is a vascular marker of solid tumors and metastases. Cancer Res., 2007, 67: 10948-10957.

[8] Kaplan RN, . VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature, 2005, 438: 820-827.

[9] Mhawech P, Dulguerov P, Assaly M, Ares C, Allal AS. EB-D fibronectin expression in squamous cell carcinoma of the head and neck. Oral. Oncol., 2005, 41: 82-88.

[10] Dikic I. Proteasomal and autophagic degradation systems. Annu. Rev. Biochem, 2017, 86: 193-224.

[11] Yang Z, Klionsky DJ. Eaten alive: a history of macroautophagy. Nat. Cell Biol., 2010, 12: 814-822.

[12] Nakatogawa H. Mechanisms governing autophagosome biogenesis. Nat. Rev. Mol. Cell Biol., 2020, 21: 439-458.

[13] Moscat J, Karin M, Diaz-Meco MT. p62 in cancer: signaling adaptor beyond autophagy. Cell, 2016, 167: 606-609.

[14] Pankiv S, . p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J. Biol. Chem., 2007, 282: 24131-24145.

[15] Lamark T, . Interaction codes within the family of mammalian Phox and Bem1p domain-containing proteins. J. Biol. Chem., 2003, 278: 34568-34581.

[16] Wooten MW, . The p62 scaffold regulates nerve growth factor-induced NF-kappaB activation by influencing TRAF6 polyubiquitination. J. Biol. Chem., 2005, 280: 35625-35629.

[17] Lin X, . Interaction domains of p62: a bridge between p62 and selective autophagy. DNA Cell Biol., 2013, 32: 220-227.

[18] Islam, M. A., Sooro, M. A. & Zhang, P. Autophagic regulation of p62 is critical for cancer therapy. Int. J. Mol. Sci. 19, https://doi.org/10.3390/ijms19051405 (2018).

[19] Wurzer B, . Oligomerization of p62 allows for selection of ubiquitinated cargo and isolation membrane during selective autophagy. Elife, 2015, 4

[20] Lamark T, Kirkin V, Dikic I, Johansen T. NBR1 and p62 as cargo receptors for selective autophagy of ubiquitinated targets. Cell Cycle, 2009, 8: 1986-1990.

[21] Ichimura Y, Kominami E, Tanaka K, Komatsu M. Selective turnover of p62/A170/SQSTM1 by autophagy. Autophagy, 2008, 4: 1063-1066.

[22] Cohen-Kaplan V, . p62- and ubiquitin-dependent stress-induced autophagy of the mammalian 26S proteasome. Proc. Natl Acad. Sci. USA, 2016, 113: E7490-E7499.

[23] Liu JL, . Prognostic significance of p62/SQSTM1 subcellular localization and LC3B in oral squamous cell carcinoma. Br. J. Cancer, 2014, 111: 944-954.

[24] Terabe T, . Expression of autophagy-related markers at the surgical margin of oral squamous cell carcinoma correlates with poor prognosis and tumor recurrence. Hum. Pathol., 2018, 73: 156-163.

[25] Tang Z, . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res., 2017, 45: W98-W102.

[26] Lanczky A, . miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients. Breast Cancer Res. Treat., 2016, 160: 439-446.

[27] Chandrashekar DS, . UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia, 2017, 19: 649-658.

[28] Klionsky DJ, . Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy, 2016, 12: 1-222.

[29] Shi Y, . Delayed treatment with an autophagy inhibitor 3-MA alleviates the progression of hyperuricemic nephropathy. Cell Death Dis., 2020, 11

[30] Shin D, Kim EH, Lee J, Roh JL. RITA plus 3-MA overcomes chemoresistance of head and neck cancer cells via dual inhibition of autophagy and antioxidant systems. Redox Biol., 2017, 13: 219-227.

[31] Wu YT, . Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinase. J. Biol. Chem., 2010, 285: 10850-10861.

[32] Drose S, Altendorf K. Bafilomycins and concanamycins as inhibitors of V-ATPases and P-ATPases. J. Exp. Biol., 1997, 200: 1-8.

[33] Mizushima N, Yoshimori T, Levine B. Methods in mammalian autophagy research. Cell, 2010, 140: 313-326.

[34] Kalluri R. EMT: when epithelial cells decide to become mesenchymal-like cells. J. Clin. Invest., 2009, 119: 1417-1419.

[35] Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat. Rev. Cancer, 2009, 9: 265-273.

[36] Wang, Y. et al. Autophagy inhibition specifically promotes epithelial-mesenchymal transition and invasion in RAS-mutated cancer cells. Autophagy 1–14, https://doi.org/10.1080/15548627.2019.1569912 (2019).

[37] Qiang L, . Regulation of cell proliferation and migration by p62 through stabilization of Twist1. Proc. Natl Acad. Sci. USA, 2014, 111: 9241-9246.

[38] Baek A, . Autophagy and KRT8/keratin 8 protect degeneration of retinal pigment epithelium under oxidative stress. Autophagy, 2017, 13: 248-263.

[39] Yamashita N, . Vimentin as a poor prognostic factor for triple-negative breast cancer. J. Cancer Res. Clin. Oncol., 2013, 139: 739-746.

[40] Dauphin M, . Vimentin expression predicts the occurrence of metastases in non small cell lung carcinomas. Lung Cancer, 2013, 81: 117-122.

[41] Grassi G, . Autophagy regulates hepatocyte identity and epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions promoting Snail degradation. Cell Death Dis., 2015, 6

[42] Zada, S. et al. Control of the epithelial-to-mesenchymal transition and cancer metastasis by autophagy-dependent SNAI1 degradation. Cells 8, https://doi.org/10.3390/cells8020129 (2019).

[43] Zou, J. et al. Autophagy attenuates endothelial-to-mesenchymal transition by promoting Snail degradation in human cardiac microvascular endothelial cells. Biosci. Rep. 37, https://doi.org/10.1042/BSR20171049 (2017).

[44] Li SS, . p62/SQSTM1 interacts with vimentin to enhance breast cancer metastasis. Carcinogenesis, 2017, 38: 1092-1103.

[45] Gavriilidis C, . The MTM1-UBQLN2-HSP complex mediates degradation of misfolded intermediate filaments in skeletal muscle. Nat. Cell Biol., 2018, 20: 198-210.

[46] Szyniarowski P, . A comprehensive siRNA screen for kinases that suppress macroautophagy in optimal growth conditions. Autophagy, 2011, 7: 892-903.

[47] Nakaso K, . Transcriptional activation of p62/A170/ZIP during the formation of the aggregates: possible mechanisms and the role in Lewy body formation in Parkinson’s disease. Brain Res., 2004, 1012: 42-51.

[48] Fujita K, Maeda D, Xiao Q, Srinivasula SM. Nrf2-mediated induction of p62 controls Toll-like receptor-4-driven aggresome-like induced structure formation and autophagic degradation. Proc. Natl Acad. Sci. USA, 2011, 108: 1427-1432.

[49] Cnop M, . RNA sequencing identifies dysregulation of the human pancreatic islet transcriptome by the saturated fatty acid palmitate. Diabetes, 2014, 63: 1978-1993.

[50] B’Chir W, . The eIF2alpha/ATF4 pathway is essential for stress-induced autophagy gene expression. Nucleic Acids Res., 2013, 41: 7683-7699.

[51] Liu T, Zhang J, Li K, Deng L, Wang H. Combination of an autophagy inducer and an autophagy inhibitor: a smarter strategy emerging in cancer therapy. Front Pharm., 2020, 11: 408.

[52] Meng J, . EGCG overcomes gefitinib resistance by inhibiting autophagy and augmenting cell death through targeting ERK phosphorylation in NSCLC. Onco Targets Ther., 2019, 12: 6033-6043.

[53] Jiang T, . Metformin and docosahexaenoic acid hybrid micelles for premetastatic niche modulation and tumor metastasis suppression. Nano Lett., 2019, 19: 3548-3562.

Funding

National Natural Science Foundation of China (National Science Foundation of China)(881320108011, 81600823, 81920108012, 81870741)

China Postdoctoral Science Foundation(2017M611332, 2019M661177)

Natural Science Foundation of Jilin Province (Natural Science Foundation of Jilin Province of China)(JLS22019378-28)

Bethune Project of Jilin University (2018A06, 2015340) Jilin Scientific and Technological Development Program (20170101093JC)